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Minimally invasive techniques to access subcutaneous adipose tissue for glucose monitoring are successfully applied in type1
diabetic and critically ill patients. During critical illness, the addition of a lactate sensor might enhance prognosis and early
intervention. Our objective was to evaluate SAT as a site for lactate measurement in critically ill patients. In 40 patients after
major cardiac surgery, arterial blood and SAT microdialysis samples were taken in hourly intervals. Lactate concentrations from
SAT were prospectively calibrated to arterial blood. Analysis was based on comparison of absolute lactate concentrations (arterial
blood vs. SAT) and on a 6-hour lactate trend analysis, to test whether changes of arterial lactate can be described by SAT lactate.
Correlation between lactate readings from arterial blood vs. SAT was highly signiﬁcant (r2 = 0.71, P<. 001). Nevertheless, 42%
of SAT lactate readings and 35% of the SAT lactate trends were not comparable to arterial blood. When a 6-hour stabilization
period after catheter insertion was introduced, 5.5% of SAT readings and 41.6% of the SAT lactate trends remained incomparable
to arterial blood. In conclusion, replacement of arterial blood lactate measurements by readings from SAT is associated with a
substantial shortcoming in clinical predictability in patients after major cardiac surgery.
Copyright © 2009 Martin Ellmerer et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The importance of lactate to monitor the metabolic stress
response has been recognized long time ago in patients with
circulatoryfailure[1].Ingeneral,bloodlactatehasbeencon-
sidered as a marker of tissue hypoxia [2], while recent inves-
tigations also suggest that elevated levels of catecholamines
play an important role in lactic acid production during acute
diseases [3]. In the meanwhile, a large body of evidence
from experimental and clinical studies established a tight
association between hyperlactatemia and mortality in many
diagnostic groups [4–9] and in 2001, Smith and colleagues
were among the ﬁrst using lactate levels as admission criteria
for early intensive care medicine [8]. Nowadays, lactate levels
are measured in critically ill patients on a routine basis using
blood gas analysis and hyperlactatemia prompts clinicians
to initiate further diagnostic and therapeutic actions. Both
absolute levels and proﬁles (trend information) of the blood
lactate concentration provide important information about
the ongoing pathophysiological processes of critically ill
patients [10].
Subcutaneous adipose tissue (SAT) has been suggested
as a possible alternative site for the measurement of glucose
in diabetic and also in critically ill patients [11]. Several
technologies have already been made commercially available
for subcutaneous glucose monitoring [12, 13]a n dw i t h
lactate as an additional metabolic parameter, this minimally
invasive technique could substantially enhance the ﬁeld of
application in clinical routine to improve prognosis and
enable early therapeutic interventions. Patients recovering2 International Journal of Endocrinology
Table 1: Baseline characteristics.
Graz Prague Total
Patients [n]2 0 2 0 4 0
Age [years] 68.6 ±76 6 .0 ±11 67.3 ±9
Female [n]5 3 8
Ethnicity: Caucasian [n]2 0 2 0 4 0
BMI [kg/m2]2 8 .2 ±4.92 7 .0 ±4.02 7 .6 ± 4.4
History of Diabetes [n] 6 10 16
BP syst. [mmHg] 108 ±10 119 ±10 114 ± 11
BP diast. [mmHg] 54 ±55 7 ±55 5 ± 5
Heart Rate 90 ±10 88 ±78 9 ± 9
APACHE II
§ score 10.1 ±3.21 1 .4 ±4.51 0 .7 ± 3.9
Dataaremean ±SD,[n]numberofpatients; §Acutephysiologyandchronic
health evaluation II score [14].
from major cardiac surgery are at high risk for complications
and might beneﬁt from a more close and accurate metabolic
monitoring. Continuous subcutaneous lactate measurement
could replace infrequent arterial measurement and conse-
quently allow early therapeutic decisions to correct tissue
oxygenation problems before they appear critical. However,
careful evaluation of SAT versus blood lactate measurements
using criteria as deﬁned from a clinical perspective has
not been performed to date. Therefore, the objective of
the present study was ﬁrst, to establish clinical evaluation
criteria for SAT versus arterial blood lactate measurement,
a n ds e c o n dt oi n v e s t i g a t ew h e t h e rm e a s u r e m e n t sf r o mS A T
could be used to replace arterial blood lactate measurements
in patients admitted to an intensive care unit (ICU) after
major cardiac surgery.
2.MaterialsandMethods
2.1. Patients. Forty adult patients from two diﬀerent inten-
sive care units were investigated after major cardiotho-
racic surgery (coronary artery bypass grafting 70%, valve
replacement 15%, both 5%, aortic root replacement 10%
of patients). Patients were included into the study after
admission to the ICU for the duration of ICU stay but for
a maximum period of 48 hours (mean: 42 hours, range: 15
to 48 hours). Exclusion criteria were (1) mental incapacity
or language barriers precluding adequate understanding or
cooperation and (2) any disease or condition which the
investigatorortreatingphysicianfeltwouldinterferewiththe
trial or patient safety. Signed informed consent was obtained
from all patients before surgery and before any trial-related
activities. Patient characteristics are depicted in Table 1.T h e
study was approved by the local Ethics Committee at Charles
University Prague and at Medical University Graz.
2.2. Deﬁnition of Clinical Evaluation Criteria for Lactate
Measurements. During clinical routine, measurement of
absolute lactate levels, preferably from arterial blood, has
been established as state-of-the-art technology. In addition,
information about lactate trends (increase/decrease/stable)
has been used to provide clinical information about the
patient health status, clinical course, and prognosis factor.
Therefore, for the present investigation, lactate concentra-
tions were evaluated regarding levels of absolute concen-
trations and regarding lactate trend information (change of
lactate concentrations over time).
2.2.1. Evaluation Criteria Based on Absolute Lactate Con-
centrations. Clinical thresholds were deﬁned based on data
from literature showing that signiﬁcant increments in
mortality rates are observed when speciﬁc cut-oﬀ values
for blood lactate are crossed [4–9]. The deﬁnition of
selected thresholds and the zones according to the severity
of violation were acknowledged by clinical experts from
participating centers before data analysis. Subcutaneous
adipose tissue lactate (satLAC) measurements were deﬁned
as acceptable if localized in the same concentration range
between two threshold limits of arterial reference lactate
readings (artLAC). A violation was deﬁned when satLAC
and artLAC were not in the same range, what would result
in erroneous treatment guidance. Lactate concentrations
below 1.5mM were considered normal [8]. Blood lactate
concentrations ranging between 1.5 and 5mM were deﬁned
as pathologically elevated, with an additional threshold
deﬁned at 3.5mM [6]. Lactate concentrations in this range
are already associated with a signiﬁcantly higher risk of
mortality for several critically ill patient populations. Lactate
concentrations ranging between 5 and 10mM have been
associatedwithasubstantiallyhigherriskofdeathintheICU
andwerethereforedeﬁnedasconcentrationswithinastateof
emergencywithrequestforfurtherdiagnosisandtherapeutic
intervention. Finally, lactate concentrations above 10mM
have been associated with extremely high risk of death and
therefore represent a life threatening condition for a patient
attheICU.Afterpredeﬁnitionofthesethresholds,astandard
xy-graph with reference arterial blood lactate readings on
the x-axis and SAT lactate readings on the y-axis including
the predeﬁned ranges on the respective axis was established
(Figure 1(a)). A general error for SAT lactate readings of
±20% was accepted. Clinical experts were then asked to
deﬁne zones indicating acceptable and 1st, 2nd, and 3rd
order of unacceptable lactate measurement.
2.2.2. Evaluation Criteria Based on Lactate Trend Analysis.
The following criteria were deﬁned to evaluate whether
the lactate trend (increase/decrease or stable lactate con-
centration) as measured in arterial blood can be replaced
by measurements from SAT. A 6-hour time interval was
deﬁned as clinically relevant for lactate trend evaluation.
We arbitrarily deﬁned a 6-hour interval as average-time
period for clinical decision making and as adequate to
detect signiﬁcant changes in the clinical status of a patient.
Stable lactate concentrations (over a period of 6 hours) were
deﬁned within ±20% relative change of the arterial blood
lactate concentration as indicated by vertical-dashed lines
in Figure 1(b). Clinical experts were then asked to deﬁne
the maximum acceptable relative error for underestimation
and overestimation of speciﬁc lactate changes, that is, a 60%
decrease, no change, a 50% increase, and a 100% increaseInternational Journal of Endocrinology 3
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Figure 1: (a) Clinical evaluation of absolute lactate levels from subcutaneous adipose tissue (satLAC) on the y-axis versus reference
measurements from arterial blood (artLAC) on the x-axis. Clinical lactate grid as described in the method section is indicated as hatched
areas. (b) 6-hour lactate trend analysis with respective clinically acceptable and unacceptable ranges as described in the method section.
Relative 6-hour lactate trend of reference arterial blood lactate readings (Δ artLAC) and calibrated subcutaneous lactate readings (Δ satLAC)
are indicated on x-axis and y-axis, respectively. Upper and lower thick lines represent limits for acceptable lactate trend identiﬁcation
from subcutaneous adipose tissue measurements. Vertical-hatched lines indicate thresholds for decreasing and increasing reference lactate
concentrations.
of the reference lactate concentration within 6 hours of
time. The graph shown in Figure 1(b) indicates the relative
change of the lactate concentration in arterial blood on the
x-axis and in SAT on the y-axis and includes the range for
acceptable lactate trends as measured in SAT (area between
upper and lower thick lines).
2.3. Protocol. Characteristic information about the patients
including demographic data, medical history, concomitant
medication, body composition, vital signs, and laboratory
analysis from routine laboratory assessment was obtained
during a screening visit prior to surgery. After admission
to the ICU, patients were included into the trial. For
samplingofinterstitialﬂuidfromSATstandardmicrodialysis
technique was applied. A microdialysis catheter (CMA 60,
Stockholm, Sweden) was inserted on the left or right side of
the periumbilical region. Abdominal location of the micro-
dialysis catheter was chosen as the easiest accessible place,
not disturbing any surgical or monitoring procedures. The
catheter was connected to a microinfusion pump (CMA 107,
Stockholm, Sweden) [15, 16] and was constantly perfused
at a ﬂow rate of 1μL/minute with an isotonic solution of
5% mannitol [17]. At least 60 minutes after insertion of the
microdialysiscatheterexperimentswerestartedanddialysate
was continuously sampled and collected in hourly fractions
(E.G. from TIME 0800 until 0900) in interstitial sampling
vials (CMA, Stockholm, Sweden). Arterial blood samples
were collected in hourly intervals (E.G. at TIME 0800 and
0900), at the same time when SAT sampling vials were
changed. Experiments ended at the latest 48 hours after start
of the study or when patients were transferred from the ICU
upon decision of the treating physician.
2.4. Analysis. Arterial blood lactate concentrations were
measuredbyroutinebloodgasanalysisusingstandardpoint-
of-care testing devices (Graz: Omni S, Roche Diagnostics,
Basel, Switzerland; Prague: ABL 700, Radiometer Medical,
Copenhagen, Denmark). Samples from SAT dialysate were
stored at −70
◦C immediately after sampling and were ana-
lyzed at a central laboratory (Joanneum Research GesmbH,
Graz,Austria).Dialysatesamplesfromsubcutaneousadipose
tissue were analyzed for lactate using a Cobas Mira Ana-
lyzer (Roche Diagnostics, Basel, Switzerland) using standard
enzymatic assays (Roche Diagnostics GmbH, Mannheim),
and sodium and potassium using a ﬂame photometer
(Instrumentation Laboratory GmbH, Vienna, Austria) after
the ﬁnalization of the study at both participating centers.
Intrarun (interrun) coeﬃcients of variation were 5.8% to
1.0% (10% to 0.9%) and 1.7% to 0.4% (1.5% to 0.4%) for
lactate and sodium for limit of quantiﬁcation to maximum
measurement range, respectively.
2.5. Calculations and Calibration. Data analysis of SAT
lactate concentrations was based on fractionized samples of
dialysate lactate concentrations from subcutaneous adipose
tissue (diaLAC). Corresponding hourly measurements of
arterial blood lactate (artLAC) were averaged between
beginning (E.G. TIME 0800) versus end (E.G. TIME 0900)4 International Journal of Endocrinology
of the interstitial sampling interval. Lactate in SAT dialysate
(diaLAC) was calibrated using a prospective 2-step cali-
bration approach, ﬁrst using the ionic reference technique,
based on the correction of diaLAC, by multiplying with
the ratio of sodium in interstitial ﬂuid by blood levels, as
previously indicated in greater detail [17, 18], to calculate
the actual lactate concentration in SAT and second, using a
one-point calibration procedure to obtain a lactate proﬁle
fromSATcomparabletoarterialbloodlactateconcentrations
(diaLAC
2-step calibration
−−−−−−−−−→ satLAC).Asasecondcalibrationstep,
a one-point calibration procedure was applied. Using this
procedure, the ratio between the ﬁrst lactate reading from
SAT and the average of the two corresponding blood lactate
readings (artLAC) was used to calculate the SAT derived
lactate proﬁle (satLAC). One-point instead of multiple point
calibration was chosen to establish a critical evaluation of
SAT derived lactate measurements [19].
2.6. Statistical Analysis. Normal distribution of data was
tested using Shapiro-Francia test. Bland and Altman analysis
was used to compare arterial with prospectively calibrated
interstitial lactate concentrations. P-values smaller than 0.05
were considered statistically signiﬁcant.
3. Results
Application of the microdialysis procedure in subcutaneous
adipose tissue was well tolerated and no adverse events
related to the interstitial sampling procedure occurred
during or after the experiments. Forty critically ill patients
were investigated for a period of 41.9 ± 12.1h o u r s( m e a n
±SD) and a total of 1550 paired lactate measurements
were analyzed to clinically evaluate the relation between
arterial blood and subcutaneous adipose tissue (SAT) lactate
measurements. Noradrenalin was used during the ICU stay
in 25 patients (63%), whereas dobutamin was used in 7
patients (18%) at doses of 0.09 ± 0.08μg/kg/minute and
4.9 ± 2.4μg/kg/minute, respectively.
3.1. Clinical Evaluation Based on Absolute Lactate Concen-
trations. For the evaluation of absolute interstitial lactate
measurements 1550 paired readings were considered. The
distribution of arterial blood lactate readings was as follows,
57.7% were found in the normal range (<1.5mM), 38.1%
were found in the range between 1.5 and 5mM, 2.8%
of the readings were found in the critical range >5mM,
and <10mM and 1.4% of the readings were found above
10mM. Clinical evaluation of arterial blood (artLAC) versus
calibrated SAT lactate (satLAC) readings is depicted in
Figure 1(a). According to the approximate precision of
arterial lactate measurement using laboratory standards, less
than 5% of the measurements in the unacceptable zone have
been considered as reliability criteria for the method. A total
of 76.5% or 1186 readings were found in the acceptable
measurement zone, 17.6% or 273 readings in the ﬁrst-order
unacceptable zone, and 5.9% or 91 readings from SAT in
the second-order unacceptable zone (Table 2). It can be
summarized that for 23.5% or 364 lactate readings from SAT,
Table 2: Clinical evaluation of absolute subcutaneous adipose tis-
sue versus arterial blood (artLAC) lactate concentrations stratiﬁed
for individual lactate ranges according to Figure 1(a).
n = 1550 hourly
paired lactate
readings
Acceptable
%
Unacceptable
[1st order] %
Unacceptable
[2nd order]
%
artLAC < 1.5mM 77.6 22.2 0.2
1.5mM≤
artLAC < 3.5mM 72.9 12.2 14.9
3.5mM ≤
artLAC < 5mM 80.0 20.0 0.0
5mM≤
artLAC < 10mM 95.4 2.3 2.3
10mM ≤ artLAC 95.2 4.8 0.0
Total readings 76.5 17.6 5.9
No readingsfrom subcutaneous adiposetissue were found within the third-
order unacceptable measurement zone.
Table 3: Clinical evaluation of 6-hour lactate trend analysis from
subcutaneous adipose tissue (Δ satLAC) versus arterial blood (Δ
artLAC). Lactate measurements are stratiﬁed to positive, stable and
negative lactate trends as indicated in Figure 1(b).
n = 245 6-hourly
paired lactate
trends
Acceptable
measurement
%
Unacceptable
falsely high %
Unacceptable
falsely low %
Positive trend
(>20%) 61.9 11.1 27.0
Negative trend
(< −20%) 66.7 27.0 6.3
No change
(±20%) 66.4 20.9 12.7
Total trend
analysis 65.3 19.9 14.8
no reliable information about the actual reference arterial
blood lactate concentration can be obtained.
To test whether a 6-hour stabilization period of the
microdialysis system would improve the relation between
SAT and arterial lactate readings we performed a diﬀerent
calibration approach, that is, we directly calibrated SAT
lactate to the arterial blood concentration at hour 6 instead
of hour 1 and considered only the data from hour 6
to 48 for clinical evaluation. This modiﬁed procedure,
improved the relation between SAT and arterial blood, yet
the results indicate that still 5.5% of the readings were in the
unacceptable measurement zone (see Table 4).
3.2. Clinical Evaluation Based on 6-Hour Lactate Trends.
For the evaluation of 6-hour lactate trends, a total of 245
paired trends were provided by the analysis and compared
between reference trends in arterial blood (Δ artLAC) and
trends from SAT (Δ satLAC). The overall distribution of
lactate trends with the respective clinically acceptable and
unacceptable ranges is indicated in Figure 1(b). Most of the
overall lactate trends (65.3%) as measured in SAT were in theInternational Journal of Endocrinology 5
Table 4: Clinical evaluation of absolute subcutaneous adipose tis-
sue versus arterial blood (artLAC) lactate concentrations stratiﬁed
for individual lactate ranges after 6-hour one-point calibration.
n = 1369 hourly
paired lactate
readings
Acceptable
%
Unacceptable
[1st order] %
Unacceptable
[2nd order]
%
artLAC < 1.5mM 96.1 3.9 0.0
1.5mM≤
artLAC < 3.5mM 90.9 9.1 0.0
3.5mM ≤
artLAC < 5mM 100.0 0.0 0.0
5mM≤
artLAC < 10mM 96.6 3.4 0.0
10mM ≤ artLAC 100.0 0.0 0.0
Total readings 94.5 5.5 0.0
Table 5: Clinical evaluation of 6-hour lactate trend analysis from
subcutaneous adipose tissue (Δ satLAC) versus arterial blood (Δ
artLAC)after6-hour1-pointcalibration.Lactatemeasurementsare
stratiﬁed to positive, stable and negative lactate trends.
n = 231 6-hour
paired lactate
trends
Acceptable
measurement
%
Unacceptable
falsely high %
Unacceptable
falsely low %
Positive trend
(>20%) 60.0 12.3 27.7
Negative trend
(< −20%) 59.2 29.6 11.3
No change
(±20%) 56.7 24.7 18.6
Total trend
analysis 58.4 22.7 18.9
acceptable measurement zone; however, 34.7% were in the
unacceptable zone. Results describing the capability of SAT
lactate to identify stable, increasing and decreasing arterial
lactate trends are summarized in Table 3. In summary, the
6-hour lactate trend analyses indicated that about a third of
the 6-hour lactate trends from arterial blood would be falsely
identiﬁed by SAT lactate measurements and would provide
an unacceptable violation of the clinical interpretation of the
trend information. The analysis performed with calibration
after a 6-hour stabilization period for the microdialysis
catheter indicated that 41.6% of the measurements were in
the unacceptable zone, as summarized in Table 5.
3.3. Examples for Comparison of Lactate Time Proﬁles.
Figure 2 indicates time proﬁles for individual patient com-
parisons for artLAC versus satLAC readings using a prospec-
tive one-point calibration procedure. Upper panels indicate
examples with best relation, middle and lower panels’ results
with worst relation between artLAC and satLAC readings
according to clinical evaluation of absolute lactate readings
and 6-hour lactate trend analysis, respectively.
4. Discussion
Clinical evaluation of lactate measurements from SAT in
critically ill patients after major cardiosurgical operation
usingthemethodofmicrodialysisindicatedthatreplacement
of arterial blood lactate measurements by readings from
SAT is associated with a substantial shortcoming in clinical
predictability in patients after major cardiac surgery.
Hyperlactatemia has clearly been associated with poor
clinical outcome [4–9] and therefore, the deﬁnition of
diﬀerent lactate ranges for clinical evaluation of lactate
measurements from SAT was based on studies investigating
the relation between arterial blood lactate concentrations
and clinical outcome parameters. An important threshold
for the arterial blood lactate concentration in the critically
ill patient is the threshold between lactate normal (below
1.5mM) and lactate high (above 1.5mM). The majority of
the lactate readings of the present study were found around
this threshold level. Whereas the predictability of blood
lactate using SAT measurements was relatively good for very
high lactate concentrations above 5mM, it was only poor
around the threshold of 1.5mM, where a substantial amount
of SAT lactate readings over- and underestimated the refer-
ence blood lactate concentration suggesting that especially
within this critical range, SAT lactate measurements failed to
provide a replacement for arterial blood lactate readings.
From a clinical monitoring point of view, for example,
to guide a therapy, it is important to follow the actual
measured lactate concentration in form of a lactate proﬁle
(trend) over time [20]. Increasing lactate concentrations
over time may indicate a deteriorating health condition and
the requirement of additional diagnostic action or therapy
or may indicate the failure of a given therapeutic action,
whereas a decrease of high lactate concentrations towards
lactate normal states below 1.5mM may be considered as
an improvement in health condition or that the applied
therapeutic action has been successful. For the evaluation
of lactate trend information, 48-hour arterial lactate proﬁles
from the present investigation have been evaluated. Intensive
care physicians deﬁned a 6-hour measurement interval as
clinically relevant for the repeated measurement of lactate
concentrations within a single patient. Applying the data
of the present study to the clinical trend analysis indicated
that approximately one third of the 6-hour lactate trends
from SAT would not allow an accurate prediction of the
given change of the arterial lactate concentration. More
than 25% of the analyzed lactate increases (>20%) from
SAT would be falsely identiﬁed as stable or even decreasing
lactate concentrations. This result clearly demonstrates, that
as applied in the present experiments, lactate readings from
SAT cannot accurately predict the trend information of
arterial blood lactate readings in critically ill patients after
major cardiovascular surgery.
Reasons for these observations might be of physiological
or methodological origin. Individual lactate proﬁles as
depicted in Figure 2 suggest that both explanations could
have contributed to our ﬁndings. The divergent behavior
of SAT lactate in comparison to arterial blood lactate to a
continuous increase as shown in the left middle panel in6 International Journal of Endocrinology
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Figure 2: Time proﬁles for individual patients. Arterial lactate (closed symbols) versus subcutaneous adipose tissue lactate (open symbols)
concentrations. Panels indicate examples with diﬀerent levels of interrelation between arterial and subcutaneous adipose tissue lactate
readings.
Figure 2 can possibly be explained by lack of tissue perfu-
sion, causing tissue hypoxia. This could lead to enhanced
anaerobic conditions and pronounced lactate production in
SAT, causing only a mild systemic increase of the lactate
concentration. In contrast, the initial rise in SAT lactate
as seen in the right middle panel of Figure 2 could most
likely be explained by an initial microdialysis instability
after insertion of the catheter as frequently seen in previous
observations using this technique [11, 21, 22]. Another
important argument in favor of physiological reasons for
the present observation is the fact that in the same patient
population and using the same technology, glucose readings
from arterial blood could very well be described by readings
from SAT [11]. In contrast, for SAT lactate, only forInternational Journal of Endocrinology 7
∼50% of the patients, a reliable relation between SAT and
arterial blood was found and no other parameter such as
severity of illness (APACHE II), BMI, age, systemic blood
pressure, heart rate, medication, or the interstitial glucose
concentration were able to explain the diﬀerence between
these patients. Methodological reasons could be considered
to explain the diversity of lactate proﬁles, as for example,
a local infection at the catheter insertion site, leading to
increased local oxygen consumption, or instability of the
microdialysis exchange properties, initially after catheter
insertion.Adistinctionbetweenthesetwoeﬀectsisextremely
diﬃcult and would require a substantially higher number of
patients studied.
5. LimitationsandPossible Improvements
Limitations of the methodological approach of microdialysis
as used in the present study could contribute to the
lack of association between arterial blood and SAT lactate
readings. Diﬀerent sites of subcutaneous monitoring might
provide diﬀerent reproducibility proﬁles in comparison to
the observed results. Local tissue perfusion which is known
to be associated with the severity of illness of an individual
patient may also be associated with local adipose tissue
lactate release. Although no such correlation was observed in
thepresentinvestigation,thismayalsobeduetotherelatively
small group of patients included. Also, it seems that dif-
ferent calibration techniques (calibration immediately after
catheter insertion versus 6-hour calibration after catheter
insertion) aﬀect clinical reliability of subcutaneous lactate
readings. In light of these observations, further studies, with
a special focus on patient populations with a wide range
in severity of illness with regard to circulatory failure and
instability will allow further insight into this rather complex
topic.
6. Conclusion
Minimally invasive techniques to access subcutaneous adi-
posetissueforglucosemonitoringhavealreadybeensuccess-
fully applied in type 1 diabetic and in critically ill patients.
Especially in the critically ill patient setting, the addition
of a lactate sensor, that is, the combined measurement of
glucose and lactate might substantially enhance the clinical
application ﬁeld of such a technology. However, the results
of the present study clearly indicate that using the applied
technology and calibration approach, lactate readings from
SAT are associated with a substantial shortcoming in clinical
predictability in patients after major cardiac surgery.
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